✦ LIBER ✦

Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib

✍ Scribed by Satouchi, M; Negoro, S; Funada, Y; Urata, Y; Shimada, T; Yoshimura, S; Kotani, Y; Sakuma, T; Watanabe, H; Adachi, S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factors associated with long-term surviv

✍ ETIENNE GIROUX LEPRIEUR; ARMELLE LAVOLE; ANNE-MARIE RUPPERT; VALéRIE GOUNANT; MA 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Efficacy and tolerability of gefitinib i

✍ Cappuzzo, F; Bartolini, S; Ceresoli, G L; Tamberi, S; Spreafico, A; Lombardo, L; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB

Improvements of quality of life in patie

✍ Yanmei Zou; Hua Xiong; Shiying Yu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 76 KB

Pretreatment clinical prognostic factors

✍ Branislav Jeremic; Biljana Milicic; Aleksandar Dagovic; Jasna Aleksandrovic; Neb 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 290 KB

Elevation of soluble interleukin-2 recep

✍ Shigenori Kanazawa; Kazuyuki Yamaguchi; Yoshimi Kinoshita; Yutaka Komiyama; Miki 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 297 KB

Gefitinib-induced acute generalized exan

✍ H-C. Shih; Y-P. Hsiao; M.F. Wu; J-H. Yang 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB